A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier

T. Ooishi, N. Kumagai, N. Iwabuchi, K. Tsuchimoto, S. Kuramochi, S. Tada, S. Tsunematsu, Hidetsugu Saito, T. Morizane, H. Ishii

Research output: Contribution to journalArticle

Abstract

A 54-year-old male was admitted to our hospital because of general malaise and jaundice. He had been an asymptomatic hepatitis B surface antigen (HBsAg) carrier and persistently positive for anti-hepatitis B e antigen (HBeAg) and negative for HBV DNA polymerase. His serological examination on admission revealed negative for HBeAg and positive for HVB DNA polymerase (2930 cpm) and the stop codon point mutation from G to A at nucleotide 83 in the precore region (mutant HBV83) was detected by MSSA method. Fulminant hepatitis developed, but the he gradually recovered with a support of intensive treatment, including a plasma exchange procedure. Afterward interferon treatment was performed, which finally normalized his liver function and a mutant HBV was disappeared from his serum. In this case, we could not approve any trigger for occurrence of fulminant hepatitis associated with a HBV mutant.

Original languageEnglish
Pages (from-to)706-711
Number of pages6
JournalActa Hepatologica Japonica
Volume36
Issue number12
Publication statusPublished - 1995

Fingerprint

Hepatitis B e Antigens
DNA-Directed DNA Polymerase
Hepatitis B
Hepatitis B virus
Hepatitis
Hepatitis B Antibodies
Plasma Exchange
Terminator Codon
Hepatitis B Surface Antigens
Jaundice
Point Mutation
General Hospitals
Interferons
Nucleotides
Liver
Therapeutics
Serum
Hepatitis B virus P protein

ASJC Scopus subject areas

  • Hepatology

Cite this

Ooishi, T., Kumagai, N., Iwabuchi, N., Tsuchimoto, K., Kuramochi, S., Tada, S., ... Ishii, H. (1995). A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier. Acta Hepatologica Japonica, 36(12), 706-711.

A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier. / Ooishi, T.; Kumagai, N.; Iwabuchi, N.; Tsuchimoto, K.; Kuramochi, S.; Tada, S.; Tsunematsu, S.; Saito, Hidetsugu; Morizane, T.; Ishii, H.

In: Acta Hepatologica Japonica, Vol. 36, No. 12, 1995, p. 706-711.

Research output: Contribution to journalArticle

Ooishi, T, Kumagai, N, Iwabuchi, N, Tsuchimoto, K, Kuramochi, S, Tada, S, Tsunematsu, S, Saito, H, Morizane, T & Ishii, H 1995, 'A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier', Acta Hepatologica Japonica, vol. 36, no. 12, pp. 706-711.
Ooishi T, Kumagai N, Iwabuchi N, Tsuchimoto K, Kuramochi S, Tada S et al. A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier. Acta Hepatologica Japonica. 1995;36(12):706-711.
Ooishi, T. ; Kumagai, N. ; Iwabuchi, N. ; Tsuchimoto, K. ; Kuramochi, S. ; Tada, S. ; Tsunematsu, S. ; Saito, Hidetsugu ; Morizane, T. ; Ishii, H. / A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier. In: Acta Hepatologica Japonica. 1995 ; Vol. 36, No. 12. pp. 706-711.
@article{7738a8b0ddb1441b8aa1954f4e7280cd,
title = "A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier",
abstract = "A 54-year-old male was admitted to our hospital because of general malaise and jaundice. He had been an asymptomatic hepatitis B surface antigen (HBsAg) carrier and persistently positive for anti-hepatitis B e antigen (HBeAg) and negative for HBV DNA polymerase. His serological examination on admission revealed negative for HBeAg and positive for HVB DNA polymerase (2930 cpm) and the stop codon point mutation from G to A at nucleotide 83 in the precore region (mutant HBV83) was detected by MSSA method. Fulminant hepatitis developed, but the he gradually recovered with a support of intensive treatment, including a plasma exchange procedure. Afterward interferon treatment was performed, which finally normalized his liver function and a mutant HBV was disappeared from his serum. In this case, we could not approve any trigger for occurrence of fulminant hepatitis associated with a HBV mutant.",
author = "T. Ooishi and N. Kumagai and N. Iwabuchi and K. Tsuchimoto and S. Kuramochi and S. Tada and S. Tsunematsu and Hidetsugu Saito and T. Morizane and H. Ishii",
year = "1995",
language = "English",
volume = "36",
pages = "706--711",
journal = "Acta Hepatologica Japonica",
issn = "0451-4203",
publisher = "Japan Society of Hepatology",
number = "12",

}

TY - JOUR

T1 - A case of fulminant hepatitis B occurred in an asymptomatic hepatitis B virus carrier

AU - Ooishi, T.

AU - Kumagai, N.

AU - Iwabuchi, N.

AU - Tsuchimoto, K.

AU - Kuramochi, S.

AU - Tada, S.

AU - Tsunematsu, S.

AU - Saito, Hidetsugu

AU - Morizane, T.

AU - Ishii, H.

PY - 1995

Y1 - 1995

N2 - A 54-year-old male was admitted to our hospital because of general malaise and jaundice. He had been an asymptomatic hepatitis B surface antigen (HBsAg) carrier and persistently positive for anti-hepatitis B e antigen (HBeAg) and negative for HBV DNA polymerase. His serological examination on admission revealed negative for HBeAg and positive for HVB DNA polymerase (2930 cpm) and the stop codon point mutation from G to A at nucleotide 83 in the precore region (mutant HBV83) was detected by MSSA method. Fulminant hepatitis developed, but the he gradually recovered with a support of intensive treatment, including a plasma exchange procedure. Afterward interferon treatment was performed, which finally normalized his liver function and a mutant HBV was disappeared from his serum. In this case, we could not approve any trigger for occurrence of fulminant hepatitis associated with a HBV mutant.

AB - A 54-year-old male was admitted to our hospital because of general malaise and jaundice. He had been an asymptomatic hepatitis B surface antigen (HBsAg) carrier and persistently positive for anti-hepatitis B e antigen (HBeAg) and negative for HBV DNA polymerase. His serological examination on admission revealed negative for HBeAg and positive for HVB DNA polymerase (2930 cpm) and the stop codon point mutation from G to A at nucleotide 83 in the precore region (mutant HBV83) was detected by MSSA method. Fulminant hepatitis developed, but the he gradually recovered with a support of intensive treatment, including a plasma exchange procedure. Afterward interferon treatment was performed, which finally normalized his liver function and a mutant HBV was disappeared from his serum. In this case, we could not approve any trigger for occurrence of fulminant hepatitis associated with a HBV mutant.

UR - http://www.scopus.com/inward/record.url?scp=0029583017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029583017&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 706

EP - 711

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 12

ER -